Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis.

Sobieraj DM, Weeda ER, Nguyen E, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE, Baker WL.

JAMA. 2018 Apr 10;319(14):1485-1496. doi: 10.1001/jama.2018.2769.

PMID:
29554195
2.

Association of Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists With Asthma Control in Patients With Uncontrolled, Persistent Asthma: A Systematic Review and Meta-analysis.

Sobieraj DM, Baker WL, Nguyen E, Weeda ER, Coleman CI, White CM, Lazarus SC, Blake KV, Lang JE.

JAMA. 2018 Apr 10;319(14):1473-1484. doi: 10.1001/jama.2018.2757.

PMID:
29554174
3.
4.

RCT of the effect of berryfruit polyphenolic cultivar extract in mild steroid-naive asthma: a cross-over, placebo-controlled study.

Power S, Williams M, Semprini A, Munro C, Caswell-Smith R, Pilcher J, Holliday M, Fingleton J, Harper J, Hurst R, Weatherall M, Beasley R, Braithwaite I.

BMJ Open. 2017 Mar 20;7(3):e013850. doi: 10.1136/bmjopen-2016-013850.

5.

Comparison of fluticasone propionate with budesonide administered via nebulizer: a randomized controlled trial in patients with severe persistent asthma.

Lin J, Chen P, Liu C, Kang J, Xiao W, Chen Z, Tang H, Du X, Liu C, Luo L.

J Thorac Dis. 2017 Feb;9(2):372-385. doi: 10.21037/jtd.2017.02.51.

6.

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy.

Svedsater H, Stynes G, Wex J, Frith L, Leather D, Castelnuovo E, Detry M, Berry S.

Asthma Res Pract. 2016 Feb 8;2:4. doi: 10.1186/s40733-015-0016-0. eCollection 2016.

7.

High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.

Paggiaro P, Corradi M, Latorre M, Raptis H, Muraro A, Gessner C, Siergiejko Z, Scuri M, Petruzzelli S.

BMC Pulm Med. 2016 Dec 9;16(1):180.

8.

Effect of common comparators in indirect comparison analysis of the effectiveness of different inhaled corticosteroids in the treatment of asthma.

Kunitomi T, Hashiguchi M, Mochizuki M.

PLoS One. 2015 Mar 20;10(3):e0120836. doi: 10.1371/journal.pone.0120836. eCollection 2015.

9.

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.

Beasley RW, Donohue JF, Mehta R, Nelson HS, Clay M, Moton A, Kim HJ, Hederer BM.

BMJ Open. 2015 Feb 3;5(2):e006131. doi: 10.1136/bmjopen-2014-006131.

10.

Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review.

Hislop J, Adewuyi TE, Vale LD, Harrild K, Fraser C, Gurung T, Altman DG, Briggs AH, Fayers P, Ramsay CR, Norrie JD, Harvey IM, Buckley B, Cook JA; DELTA group.

PLoS Med. 2014 May 13;11(5):e1001645. doi: 10.1371/journal.pmed.1001645. eCollection 2014 May. Review.

11.

Improving asthma during pregnancy with dietary antioxidants: the current evidence.

Grieger JA, Wood LG, Clifton VL.

Nutrients. 2013 Aug 14;5(8):3212-34. doi: 10.3390/nu5083212. Review.

12.

Emerging role of long acting muscarinic antagonists for asthma.

Lipworth BJ.

Br J Clin Pharmacol. 2014 Jan;77(1):55-62. doi: 10.1111/bcp.12123. Review.

13.

Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial.

Papi A, Nicolini G, Crimi N, Fabbri L, Olivieri D, Rossi A, Paggiaro P.

Respir Res. 2012 Jun 25;13:54. doi: 10.1186/1465-9921-13-54.

14.

Asthma outcomes: pulmonary physiology.

Tepper RS, Wise RS, Covar R, Irvin CG, Kercsmar CM, Kraft M, Liu MC, O'Connor GT, Peters SP, Sorkness R, Togias A.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S65-87. doi: 10.1016/j.jaci.2011.12.986. Review.

15.
16.

Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS).

Twiss J, Doward LC, McKenna SP, Eckert B.

Health Qual Life Outcomes. 2010 Oct 11;8:117. doi: 10.1186/1477-7525-8-117.

17.

The Asthma Control and Communication Instrument: a clinical tool developed for ethnically diverse populations.

Patino CM, Okelo SO, Rand CS, Riekert KA, Krishnan JA, Thompson K, Quartey RI, Perez-Williams D, Bilderback A, Merriman B, Paulin L, Hansel N, Diette GB.

J Allergy Clin Immunol. 2008 Nov;122(5):936-943.e6. doi: 10.1016/j.jaci.2008.08.027. Epub 2008 Oct 11.

18.

Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach.

de Vet HC, Ostelo RW, Terwee CB, van der Roer N, Knol DL, Beckerman H, Boers M, Bouter LM.

Qual Life Res. 2007 Feb;16(1):131-42. Epub 2006 Oct 11.

20.

Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis.

Rodrigo GJ, Castro-Rodriguez JA.

Thorax. 2005 Sep;60(9):740-6. Epub 2005 Jul 29. Review. Erratum in: Thorax. 2006 Mar;61(3):274. Thorax. 2008 Nov;63(11):1029. Thorax. 2006 May;61(5):458. Thorax. 2010 Dec;65(12):1118.

Supplemental Content

Support Center